Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High‐Grade Serous Ovarian Cancer: A Retrospective Cohort Study
OS for Stage IVB HGSOC follows a hierarchical pattern: PCS, ICS, and chemotherapy. Disease distribution guides treatment and residual tumor after CS correlates with survival.
Authors
- Marcus Q. Bernardini (ORCID: https://orcid.org/0000-0001-7022-8308)
- Anouk Benseler (ORCID: https://orcid.org/0000-0002-0736-1250)
- Adina Tanen
- Taymaa May (ORCID: https://orcid.org/0000-0002-9242-2969)
- Lisa M. Avery (ORCID: https://orcid.org/0000-0002-8431-5143)
- Geneviève Bouchard‐Fortier (ORCID: https://orcid.org/0000-0002-7104-1518)
- Liat Hogen
Institutions
- Brigham and Women's Hospital (US)
- University Health Network (CA)
- University of Toronto (CA)
- Dana-Farber Cancer Institute (US)
- Public Health Ontario (CA)
- Sinai Health System (CA)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1002/jso.70142
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Toronto